Pharmafile Logo
Pharmafocus logo
Advanced Search
mondher_mahjoubi

AZ oncology head leaves to become Innate Pharma chairman

December 19, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Innate Pharma

French firm Innate Pharma has announced that the current-AstraZeneca head of oncology is joining the company as chairman of the …

News
ionis

Ionis achieves successful Phase 3 trial to treat rare diseases

December 19, 2016
Manufacturing and Production, Research and Development Akcea, Ionis, rare disease

Ionis Pharmaceutial announced that the results of a Phase 3 trial into its treatment for hypertriglyceridemia met its primary endpoint. …

News
astrazeneca_building_white

AZ secures rights from Ionis for first-ever antisense KRAS cancer drug in $165m deal

December 19, 2016
Research and Development, Sales and Marketing AstraZeneca, Ionis, KRAS

AstraZeneca has paid a $28 million milestone payment in its partnership with Ionis Pharmaceuticals over the licensing rights to anticancer …

News
robert_ross_md

Robert Ross joins Surface Oncology as chief medical officer

December 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio

Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …

Appointment
nice_reception_small_size

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …

Feature
fda2outsideweb

FDA orders new label warnings over anaesthetics risk in children

December 19, 2016
Research and Development, Sales and Marketing FDA, anaesthetics

The FDA has announced a new Drug Safety Communication for label warnings on general anaesthetic and sedation products because of …

News
novartis_window

Novartis acquires Ziarco adding to dermatology pipeline

December 19, 2016
Sales and Marketing Novartis, Ziarco, eczema, oral

Novartis has announced that it will acquire UK-based Ziarco, to add Ziarco’s lead investigational oral treatment for moderate-to-severe eczema to …

News
smoke-1001664_1280

FDA removes black box warning on Pfizer’s anti-smoking medication

December 19, 2016
Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking

The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …

News
1280px-epi-pen_1

Mylan launches $300 generic EpiPen to calm pricing controversy

December 16, 2016
Sales and Marketing Mylan, epipen

Mylan has launched a generic alternative to its flagship EpiPen auto-injector, a move to placate the outbreak of industry indignity …

News
bill_anderson

Genentech announces Bill Anderson as new CEO

December 16, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bill Anderson, Genentech, Roche

Genentech, the biotech subsidiary of Roche, has announced that Genentech veteran, Ian Clark, will retire as CEO on 1 January. …

Appointment
nurofen

Nurofen maker hit by $6m fine over “misleading conduct”

December 16, 2016
Sales and Marketing Nurofen, Reckitt Benckiser

After a case last year levied by the Australian Federal Court over “misleading conduct” concerning the marketing of its branded …

News
1511671_logo_1456919640

MSD-Gilead patent squabble ends in $2.54 billion verdict

December 16, 2016
Medical Communications

A patent lawsuit between Gilead Sciences and MSD, known as Merck in the US, has resulted in MSD being awarded …

News
top_ten_1

Top Ten most popular articles on Pharmafile.com this week

December 16, 2016
Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

Christmas is nearly here, but there isn’t much Christmas cheer to be had in the pharmaceutical industry. It’s been a …

News
dominos

Six generics companies hit by 20-state-strong lawsuit

December 16, 2016
Medical Communications Heritage, Mylan, Teva

Following hot on the heels of yesterday’s news that a former CEO and president of Heritage Pharmaceuticals had been charged …

News

Actavis UK overcharged NHS with 12,000% price hike, watchdog says

December 16, 2016
Medical Communications, Sales and Marketing Actavis, CMA, NHS

Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …

News

Insider interview: NICE discusses its planned ‘fast-track’ appraisal process

December 16, 2016
Medical Communications, Sales and Marketing NICE

Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …

News
bart_de_strooper_cropped

Bart de Strooper chosen as new director of UK Dementia Research Institute

December 15, 2016

Bart de Strooper has been chosen as the new director of the UK Dementia Research Institute (UK DRI), and University …

Appointment
shutterstock_311949818

First human trial of tau-targeting Alzheimer’s vaccine shows promise

December 15, 2016
Medical Communications, Research and Development Alzheimer's

The latest in a succession of promising announcements surrounding Alzheimer’s R&D, researchers at the Karolinska Institutet in Stockholm, Sweden have …

News
gsk_wall

GSK opens state-of-the-art global vaccine centre

December 15, 2016
Manufacturing and Production, Medical Communications

GlaxoSmithKline has opened its new global vaccines R&D centre in Rockville, Maryland, to add to its two existing facilities in …

News

Pfizer’s next blockbuster given FDA approval

December 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, atopic dermatitis, eczema

Pfizer announced that it had received approval for its eczema treatment, Eucrisa, for patients of two years of age and …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026